BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Seeing is Believing - 3D Scanning with Tecan's Infinite(R) M1000


1/13/2011 11:07:41 AM

January 13, 2011 -- Scientists at the Center for Integrated Protein Science Munich (CIPSM), based at Ludwig¬Maximilians University Munich (LMU), Germany, have taken advantage of the 3D scanning capabilities of the premium Quad4 Monochromators™-based Infinite M1000 microplate reader to investigate nanobodies.

Professor Heinrich Leonhardt, Professor of Molecular Human Biology at LMU, explained: “We have been able to use the 3D scanning capability of the M1000 to study nanobody¬induced changes of the spectral properties of GFP in living cells. The results are really beautiful.” Dr Carina Frauer, a scientist at LMU, continued: “We co-expressed GFP in cells with specific nanobodies which modulate the spectral properties of GFP. 3D scanning shows excitation and emission on the same plot, very nicely illustrating the shift in GFP fluorescence excitation and emission wavelengths induced by nanobody binding.”

Professor Leonhardt concluded: “The instrument is flexible, easy to use and very fast, which has increased the speed of the assay. The software is simple to understand and, if we need any additional advice, Tecan is happy to help. We focus on developments in technology and the application of new methods, and the Infinite M1000’s versatility really helps in this.”

For more information on Tecan’s Infinite M1000 visit http://www.tecan.com/infinitem1000

For more information please contact

Tecan Trading AG Tanja Sager Seestrasse 103, CH-8708 Männedorf Tel +41 (0)44 922 81 11, Fax +41 (0)44 922 81 12 info@tecan.com www.tecan.com

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).

© 2010 kdm communications limited Editorial contact for further information or follow-up Antonietta Allocca at kdm communications limited, Bedford, UK Tel. +44 (0)1234 210555 Fax: +44 (0)1234 342397 email ideas@kdm-communications.com



Read at BioSpace.com

Tecan
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES